Estimation of ABO(H) isoantigen expression in bladder tumors

Area of Science:

• Oncology
• Immunology
• Urology

Background:

• ABO(H) isoantigens are important cell surface markers.
• Altered expression of isoantigens is observed in various cancers.

Purpose of the Study:

• To investigate the expression levels of ABO(H) isoantigens in bladder tumors.
• To correlate isoantigen expression with bladder cancer histology and stage.

Main Methods:

• Semiquantitative estimation of ABO(H) isoantigen expression using the red cell adherence test.
• Analysis of single epithelial cell suspensions from 89 bladder tumors and 7 normal bladder specimens.
• Blind correlation of isoantigen expression with pathological findings.

Main Results:

• Normal bladder tissues showed a mean isoantigen expression count of 86.0.
• Significantly lower expression was found in muscle-invading lesions (12.6) and flat carcinoma in situ (21.6) (p < 0.001).
• A strong correlation was observed between isoantigen expression, histological findings, and tumor stage.

Conclusions:

• ABO(H) isoantigen expression is significantly reduced in bladder tumors.
• The observed correlation supports the potential role of isoantigen measurement in bladder cancer diagnosis and prognosis.
• Further prospective studies are warranted to confirm the clinical utility of ABO(H) isoantigen assessment in bladder cancer patients.